These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 17562493

  • 21. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG, Riley DS, Heger M.
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [Abstract] [Full Text] [Related]

  • 22. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L, Schatzberg AF.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.
    Encephale; 1984 Oct; 10(3):135-8. PubMed ID: 6389091
    [Abstract] [Full Text] [Related]

  • 24. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [Abstract] [Full Text] [Related]

  • 25. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT.
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [Abstract] [Full Text] [Related]

  • 26. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [Abstract] [Full Text] [Related]

  • 27. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [Abstract] [Full Text] [Related]

  • 28. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [Abstract] [Full Text] [Related]

  • 29. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI, Nguyen H, O'Neal E, Ochs R, Kaffeman M, Borison RL.
    Psychopharmacol Bull; 1991 Oct; 27(1):67-71. PubMed ID: 1677774
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
    Herrera-Arellano A, Rodríguez-Soberanes A, de los Angeles Martínez-Rivera M, Martínez-Cruz E, Zamilpa A, Alvarez L, Tortoriello J.
    Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
    [Abstract] [Full Text] [Related]

  • 31. Kava treatment in patients with anxiety.
    Geier FP, Konstantinowicz T.
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [Abstract] [Full Text] [Related]

  • 32. A comparison on the metabolic profiling of the Mexican anxiolytic and sedative plant Galphimia glauca four years later.
    Sharma A, Cardoso-Taketa A, Choi YH, Verpoorte R, Villarreal ML.
    J Ethnopharmacol; 2012 Jun 14; 141(3):964-74. PubMed ID: 22472113
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST, Park JH, Kim M.
    Headache; 2005 Sep 14; 45(8):1004-11. PubMed ID: 16109114
    [Abstract] [Full Text] [Related]

  • 34. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
    Bernardi F, Fossi L, Faravelli C, Corsini GU, Varricchio MC.
    Riv Patol Nerv Ment; 1984 Sep 14; 105(1):1-13. PubMed ID: 6571441
    [Abstract] [Full Text] [Related]

  • 35. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I.
    J Clin Psychopharmacol; 2013 Oct 14; 33(5):643-8. PubMed ID: 23635869
    [Abstract] [Full Text] [Related]

  • 36. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL, Parmley LF.
    J Clin Psychiatry; 1978 Oct 14; 39(10 Pt 2):41-5. PubMed ID: 30767
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
    Romero-Cerecero O, Rojas G, Navarro V, Herrera-Arellano A, Zamilpa-Alvarez A, Tortoriello J.
    Planta Med; 2006 Nov 14; 72(14):1257-61. PubMed ID: 17051456
    [Abstract] [Full Text] [Related]

  • 38. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H, Malka R, Hantouche E, Lancrenon S, Guelfi JD.
    Encephale; 1991 Nov 14; 17(4):295-300. PubMed ID: 1959498
    [Abstract] [Full Text] [Related]

  • 39. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S, Lader M.
    Pharmacopsychiatry; 1992 Jul 14; 25(4):177-81. PubMed ID: 1356277
    [Abstract] [Full Text] [Related]

  • 40. Lorazepam and diazepam in the treatment of neurotic anxiety: a double-blind trial.
    Valarino F, Perez-Lopez R.
    Dis Nerv Syst; 1976 Feb 14; 37(2):58-61. PubMed ID: 1213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.